Observational studyAnnals of hematology2015

Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome.

Agnieszka Piekarska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.